Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study

被引:10
|
作者
Kjellander, Christian [1 ,2 ,3 ]
Bjorkholm, Magnus [1 ,2 ]
Kallman, Owe [4 ,5 ]
Giske, Christian G. [4 ,5 ]
Weibull, Caroline E. [6 ]
Love, Thorvardur J. [7 ,8 ,10 ,11 ]
Landgren, Ola [9 ]
Kristinsson, Sigurdur Y. [1 ,2 ,10 ,11 ]
机构
[1] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Karolinska Univ Sjukhuset Solna, Hematol Ctr, S-17176 Stockholm, Sweden
[4] Karolinska Univ Hosp, Clin Microbiol, Stockholm, Sweden
[5] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[6] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[7] Landspitali Univ Hosp, Ctr Rheumatol Res, Reykjavik, Iceland
[8] Univ Iceland, Reykjavik, Iceland
[9] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA
[10] Univ Iceland, Fac Med, Reykjavik, Iceland
[11] Landspitali Univ Hosp, Reykjavik, Iceland
关键词
Chronic lymphocytic leukemia; Infections; Prognosis; Bloodstream infections; Splenectomy; TRIMETHOPRIM-SULFAMETHOXAZOLE; HEMATOLOGICAL MALIGNANCIES; INITIAL THERAPY; FLUDARABINE; BACTEREMIA; RITUXIMAB; CANCER; CYCLOPHOSPHAMIDE; ALEMTUZUMAB; RESISTANCE;
D O I
10.1007/s00277-016-2643-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infectious complications in chronic lymphocytic leukemia (CLL) represent a major cause of morbidity and mortality. The aim of the study was to investigate temporal trends in bloodstream infections (BSIs) among patients with CLL. Individuals with blood cultures were linked to Swedish Cancer Registry and divided into three time periods (1988-1993, 1994-1999, and 2000-2006) according to year of CLL diagnosis. CLL patients (n = 275) with 1092 blood culture episodes were identified and linked to the nationwide Cause of Death Registry and Swedish Patient Registry (to retrieve information on splenectomies). The most common causes of BSI among CLL patients were Escherichia coli (11/43, 15/78, and 9/33), Streptococcus pneumoniae (7/43, 13/78, and 6/33), Pseudomonas aeruginosa (2/43, 8/78, and 3/33), Staphylococcus aureus (1/43, 6/78, and 6/33), and Viridans streptococci (5/43, 6/78, and 2/33). Coagulase-negative staphylococci was the most frequent microorganism found in blood cultures (22/70, 23/106, and 5/41, respectively) but is a frequent contaminant. Based on the largest study to date on BSI in CLL patients, we found a stable proportion of Gram-positive to Gram-negative bacteria and no temporal change of distribution was observed for BSIs 1988-2006.
引用
收藏
页码:871 / 879
页数:9
相关论文
共 50 条
  • [31] CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study
    Xue, Xinran
    Wen, Zhihao
    Zhang, Xin
    Yang, Ying
    Li, Yifei
    Liao, Ruoxi
    Zheng, Qin
    Fu, Yang
    Liu, Yu
    Liao, Hongyan
    GENES AND IMMUNITY, 2024, 25 (02) : 117 - 123
  • [32] CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study
    Xinran Xue
    Zhihao Wen
    Xin Zhang
    Ying Yang
    Yifei Li
    Ruoxi Liao
    Qin Zheng
    Yang Fu
    Yu Liu
    Hongyan Liao
    Genes & Immunity, 2024, 25 : 117 - 123
  • [33] Laboratory analysis of 124 chronic lymphocytic leukemia cases: Single center study
    Mahdi, Shams Salah
    Abd Ali Al-Sarai, Nuha
    IRAQI JOURNAL OF HEMATOLOGY, 2024, 13 (02) : 304 - 313
  • [34] Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study
    Francis, Jose
    Palaniappan, Muthiah
    Dubashi, Biswajit
    Pradhan, Suresh Chandra
    Chandrasekaran, Adithan
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (01) : 30 - 33
  • [35] Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China
    Xu, Zhenshu
    Zhang, Jinyan
    Wu, Shunquan
    Zheng, Zhihong
    Chen, Zhizhe
    Zhan, Rong
    ONCOLOGY LETTERS, 2013, 5 (04) : 1266 - 1272
  • [36] Infections in patients with chronic lymphocytic leukemia treated with fludarabine
    Anaissie, EJ
    Kontoyiannis, DP
    O'Brien, S
    Kantarjian, H
    Robertson, L
    Lerner, S
    Keating, MJ
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (07) : 559 - 566
  • [37] Viral infections and their management in patients with chronic lymphocytic leukemia
    Melchardt, Thomas
    Weiss, Lukas
    Greil, Richard
    Egle, Alexander
    LEUKEMIA & LYMPHOMA, 2013, 54 (08) : 1602 - 1613
  • [38] INITIAL CHARACTERISTICS, TREATMENT AND PROGNOSIS ACCORDING TO AGE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A SINGLE-CENTER ANALYSIS BASED ON 949 PATIENTS
    Baumann, T.
    Delgado, J.
    Santacruz, R.
    Martinez-Trillos, A.
    Royo, C.
    Navarro, A.
    Pinyol, M.
    Rozman, M.
    Pereira, A.
    Villamor, N.
    Aymerich, M.
    Lopez, C.
    Carrio, A.
    Montserrat, E.
    HAEMATOLOGICA, 2014, 99 : 323 - 323
  • [39] Gene Mutations Associated With Chronic Lymphocytic Leukemia (CLL) Among Saudi CLL Patients and Treatment Outcomes: A Single-Center Experience
    Alsayari, Mohammed A.
    Gmati, Giamal Edein M.
    Omair, Aamir
    Alhobabi, Abdullah
    Alanazi, Faisal T.
    Almutairi, Mohammed A.
    Al Faifi, Al Waleed K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [40] Bloodstream infections and patient survival with tunneled-cuffed catheters for hemodialysis: A single-center observational study
    Donati, Gabriele
    Spazzoli, Alessandra
    Croci Chiocchini, Anna Laura
    Scrivo, Anna
    Bruno, Paolo
    Conte, Diletta
    Ruggeri, Marco
    Cappuccilli, Maria
    La Manna, Gaetano
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2020, 43 (12): : 767 - 773